Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today ...
Good afternoon, everyone, and thank you for joining BridgeBio Pharma's Second Quarter 2025 Earnings Call. With me today are Neil Kumar, our CEO; Matt Outten, our Chief Commercial Officer; and Tom ...
Novo Nordisk Bangladesh have announced the start of local production of modern insulin cartridges (Penfill) in Bangladesh ...
Topline Phase 3 results of survodutide—licensed to Boehringer Ingelheim from Zealand Pharma—are more comparable to Novo ...
Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first ...
The large AI player is paying $400 million for the tiny startup, signaling a potential shift in how tech is approaching ...
Zacks Small Cap Research on MSN
ACHV: Change of command brings material funding
By John Vandermosten, CFA NASDAQ: ACHV Achieve Life Sciences, Inc. (NASDAQ: ACHV) generated significant news flow in April, announcing the arrival of a new CEO, substantial new financing, and a ...
Executives insist Novartis will return to growth in the second half, but for Q1 2026, generic erosion drove a 5% drop in revenue, including a 46% nosedive for blockbuster heart failure drug Entresto.
Aterian, Inc. (Nasdaq: ATER ) (“Aterian” or the “Company” ), a consumer products company, today announced separate transactions related to its previously announced Strategic Alternative Process. Sale ...
Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to ...
North Carolina’s milestone of exceeding $230 million in biomanufacturing workforce training investments marks an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results